Opendata, web and dolomites

iMOTED SIGNED

iMOTED Platform Built to improve Clinical Trial outcomes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 iMOTED project word cloud

Explore the words cloud of the iMOTED project. It provides you a very rough idea of what is the project "iMOTED" about.

trial    costing    huge    amount    breakeven    safe    hence    carg    point    roi    delay    turnover    give    business    investigators    prove    domestic    31    560    losses    tested    predictions    sources    registered    body    cumulative    intuitive    spend    pharma    estimations    data    clinic    feasibility    collected    companies    return    sponsors    complexity    interface    near    ec    industry    drugs    bn    considering    trials    individuals    start    usually    initially    stage    belongs    period    80    drug    opportunity    simplify    launching    simulations    beginning    alarms    2017    generation    13    market    ct    multiple    marketing    inefficient    2022    imoted    12    forecasted    software    selling    launch    delayed    designed    countries    140    2024    exceed    revenues    economic    asking    customizable    employing    whom    believe    therapy    marketed    day    time    platform    device    reduce    upwards    120    human    clinical       perform    licenses    quality    rate   

Project "iMOTED" data sheet

The following table provides information about the project.

Coordinator
BIODATUP SL 

Organization address
address: PASEO MIKELETEGUI 83
city: SAN SEBASTIAN DONOSTIA
postcode: 20009
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://biodatup.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIODATUP SL ES (SAN SEBASTIAN DONOSTIA) coordinator 50˙000.00

Map

 Project objective

Clinical Trials (CT) are designed to prove if a drug, device or therapy is safe and effective in the human body, so they are already tested in individuals. The CT investigators and sponsors spend great amount of resources on data management and project and data quality control. In 2017 more than 120,000 CT have been registered, of which near 31,000 are carried out in the EU. Usually the average duration of CT from start to marketing is 7.5 years, however, more than 80% of CT are delayed from 1 to 6 month costing to the companies upwards of 30,000 € per day per trial. In most of the cases, this delay is due to inefficient management systems. With CT conducted in over 140 countries, the complexity and rate of change in trials is increasing. Considering this huge business opportunity, we have been working in a customizable software system to manage and simplify CT development. iMOTED platform will ensure high quality data, collected from multiple sources by using real time analysis of data, a simple and intuitive interface, generation of real time alarms employing estimations, predictions & simulations In this way, we expect to reduce the economic losses that pharma industry has when launching a new drug, for whom only 2 out of 10 marketed drugs return revenues that exceed R&D costs. iMOTED belongs to the e-clinic market, which is forecasted to reach €7.6 Bn by 2022 growing at a CARG of 12.4% over the period 2017-2022. We will initially target Europe as our domestic market, to start selling the IMOTED licenses. We expect to have our breakeven point two years after the beginning of the project, a cumulative turnover of €13 M by 2022, that will give us a ROI of 560% in 2024. Hence, at this stage of development we believe that we need to perform a through feasibility study to assess for the challenges and tasks that we still must accomplish to launch iMOTED for what we are asking for EC support.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMOTED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMOTED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

MIGRATECH 4.0 (2019)

The revolution in micro-granulation technology for eco-friendly, production efficient, superior ceramic tiles

Read More